HS Code:
Piperidine (HS Code: 2933.32) is a heterocyclic organic compound, widely used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other chemical products. It serves as a key intermediate in the production of various drugs, including antihistamines, analgesics, and antipsychotics. Additionally, piperidine derivatives are utilized in the rubber industry as accelerators and in the production of pesticides. The global trade of piperidine and its derivatives is driven by the pharmaceutical and chemical industries, with significant demand in regions with strong manufacturing bases for these sectors.
Total Trade Volume
USD 250 million
Data from 2022
Source
United Nations Comtrade Database & International Trade Centre (ITC)
Average Rate
5.2%
Highest Rate
12% (applied by certain developing countries to protect domestic industries)
Lowest Rate
0% (under free trade agreements like EU-India or USMCA)
Rising demand in pharmaceutical manufacturing
Increased production and export from countries like China and India due to growing generic drug markets
2021-2022
Shift towards sustainable chemical synthesis
Encourages development of greener production methods for piperidine, impacting cost structures and trade competitiveness
2022
Regulatory scrutiny on chemical intermediates
Stricter controls on piperidine trade due to potential misuse, leading to higher compliance costs and slower trade growth
2020-2022
The European Union introduced stricter import controls on piperidine and its derivatives to monitor potential misuse in drug synthesis, requiring additional documentation and certification.
March 2023
Increased compliance costs for exporters to the EU, potentially reducing trade volume from non-compliant suppliers.
Several Indian chemical manufacturers expanded their production facilities for piperidine to meet rising global demand from the pharmaceutical sector.
July 2022
Strengthened India's position as a leading exporter, potentially leading to competitive pricing in the global market.
A bilateral agreement reduced tariffs on certain chemical intermediates, including piperidine, to facilitate smoother trade between the two countries.
October 2022
Expected to increase trade volume between the US and China, benefiting US pharmaceutical manufacturers reliant on Chinese imports.